Coagulation Factor IX, Human, recombinant

ATC (Anatomical Therapeutic Chemical Classification)

B02BD04

Therapeutic Categories

Hemostatic agent

Blood coagulation factor substitute

Foreign Names

• Factor IX coagulationis humanus (ADNr) (Latin)
• Blutgerinnungsfaktor IX vom Menschen, rekombinant (German)
• Facteur de coagulation humain, recombinant (French)

Generic Names

• rDNA IX (IS)
• Nonacog Alfa (OS: BAN, USAN)
• Nonacog Alfa (Genetical Recombination) (OS: JAN)

Brand Names

• BeneFIX
  Baxter, Spain; Baxter, Ireland; Biovitrum, Sweden; Pfizer, Switzerland; Wyeth, Austria; Wyeth, Australia; Wyeth, Belgium; Wyeth, Brazil; Wyeth, Canada; Wyeth, Chile; Wyeth, Colombia; Wyeth, Czech Republic; Wyeth, Germany; Wyeth, Denmark; Wyeth, Finland; Wyeth, France; Wyeth, Greece; Wyeth, Hungary; Wyeth, Iceland; Wyeth, Italy; Wyeth, Luxembourg; Wyeth, Netherlands; Wyeth, New Zealand; Wyeth, Sweden; Wyeth, Taiwan; Wyeth, United States; Wyeth, Venezuela; Wyeth Europa, Norway; Wyeth Pharmaceuticals, United Kingdom



• Betafact
  Swedish Orphan, Germany

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.